311 related articles for article (PubMed ID: 32201587)
21. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
22. NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department.
Holl MJ; van den Bos EJ; van Domburg RT; Fouraux MA; Kofflard MJ
Clin Cardiol; 2018 Mar; 41(3):400-405. PubMed ID: 29480582
[TBL] [Abstract][Full Text] [Related]
23. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
24. Fragmented sinoatrial dynamics in the prediction of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
Costa MD; Redline S; Soliman EZ; Goldberger AL; Heckbert SR
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H256-H271. PubMed ID: 32986961
[TBL] [Abstract][Full Text] [Related]
25. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
[TBL] [Abstract][Full Text] [Related]
26. Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels.
Al-Khalili F; Kemp-Gudmundsdottir K; Svennberg E; Fredriksson T; Frykman V; Friberg L; Rosenqvist M; Engdahl J
Open Heart; 2020; 7(1):e001200. PubMed ID: 32153793
[TBL] [Abstract][Full Text] [Related]
27. Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.
Engdahl J; Svennberg E; Friberg L; Al-Khalili F; Frykman V; Kemp Gudmundsdottir K; Fredriksson T; Rosenqvist M
Europace; 2017 Feb; 19(2):297-302. PubMed ID: 28011798
[TBL] [Abstract][Full Text] [Related]
28. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
[TBL] [Abstract][Full Text] [Related]
29. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
[TBL] [Abstract][Full Text] [Related]
30. Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation: An Ancillary Study From the OPERA Trial.
Corradi D; Saffitz JE; Novelli D; Asimaki A; Simon C; Oldoni E; Masson S; Meessen JMTA; Monaco R; Manuguerra R; Latini R; Libby P; Tavazzi L; Marchioli R; Dozza L; Cavallotti L; Aleksova A; Gregorini R; Mozaffarian D
Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008382. PubMed ID: 32654517
[TBL] [Abstract][Full Text] [Related]
31. The use of N-terminal pro-brain natriuretic peptide as a predictor of atrial fibrillation after cardiac surgery.
Kallel S; Jarrya A; Triki Z; Abdenadher M; Frikha J; Karoui A
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):403-11. PubMed ID: 23172377
[TBL] [Abstract][Full Text] [Related]
32. Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods.
Toprak B; Brandt S; Brederecke J; Gianfagna F; Vishram-Nielsen JKK; Ojeda FM; Costanzo S; Börschel CS; Söderberg S; Katsoularis I; Camen S; Vartiainen E; Donati MB; Kontto J; Bobak M; Mathiesen EB; Linneberg A; Koenig W; Løchen ML; Di Castelnuovo A; Blankenberg S; de Gaetano G; Kuulasmaa K; Salomaa V; Iacoviello L; Niiranen T; Zeller T; Schnabel RB
Europace; 2023 Mar; 25(3):812-819. PubMed ID: 36610061
[TBL] [Abstract][Full Text] [Related]
33. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
34. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular shape predicts different types of cardiovascular events in the general population.
Ambale-Venkatesh B; Yoneyama K; Sharma RK; Ohyama Y; Wu CO; Burke GL; Shea S; Gomes AS; Young AA; Bluemke DA; Lima JA
Heart; 2017 Apr; 103(7):499-507. PubMed ID: 27694110
[TBL] [Abstract][Full Text] [Related]
37. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.
Macheret F; Bartz TM; Djousse L; Ix JH; Mukamal KJ; Zieman SJ; Siscovick DS; Tracy RP; Heckbert SR; Psaty BM; Kizer JR
Heart; 2015 Sep; 101(17):1368-74. PubMed ID: 25855796
[TBL] [Abstract][Full Text] [Related]
38. Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide.
Plitt DC; Chung EH; Mounsey JP; Schwartz JD; Pursell IW; Gehi AK
Am J Cardiol; 2013 May; 111(9):1315-8. PubMed ID: 23415637
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
Börschel CS; Ortega-Alonso A; Havulinna AS; Jousilahti P; Salmi M; Jalkanen S; Veikko S; Niiranen T; Schnabel RB
Heart; 2023 Jun; 109(13):1000-1006. PubMed ID: 36801832
[TBL] [Abstract][Full Text] [Related]
40. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]